Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300069946Phase 4Completed
Phase 4 trial of esketamine in postpartum depression (PPD) (2 arms), sponsored by Wenzhou People's Hospital. Primary endpoints: Neonatal umbilical cord arterial blood gas analysis, Apgar score and 1 more. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300069946.